109 related articles for article (PubMed ID: 9258150)
1. The effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on obstructed rat bladder.
Palmer LS; Lee C; Decker RS; Lang S; Kaplan WE; Firlit CF; Cheng EY
J Urol; 1997 Sep; 158(3 Pt 2):1100-4. PubMed ID: 9258150
[TBL] [Abstract][Full Text] [Related]
2. Captopril (an inhibitor of angiotensin converting enzyme) inhibits obstructive changes in the neonatal rabbit bladder.
Cheng EY; Lee C; Decker RS; Sensibar JA; Lang S; Kaplan WE; Maizels M; Firlit CF
Urology; 1997 Sep; 50(3):465-71. PubMed ID: 9301722
[TBL] [Abstract][Full Text] [Related]
3. Survival after myocardial infarction in rats: captopril versus losartan.
Milavetz JJ; Raya TE; Johnson CS; Morkin E; Goldman S
J Am Coll Cardiol; 1996 Mar; 27(3):714-9. PubMed ID: 8606287
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II and bladder obstruction in the rat: influence on hypertrophic growth and contractility.
Persson K; Pandita RK; Waldeck K; Andersson KE
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1186-92. PubMed ID: 8945952
[TBL] [Abstract][Full Text] [Related]
5. Losartan versus captopril in elderly patients with heart failure.
Fournier A; Achard JM; Fernandez LA
Lancet; 1997 May; 349(9063):1473-4; author reply 1475. PubMed ID: 9164336
[No Abstract] [Full Text] [Related]
6. Losartan versus captopril in elderly patients with heart failure.
Ball SG
Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338
[No Abstract] [Full Text] [Related]
7. Losartan versus captopril in elderly patients with heart failure.
Sechi LA; Catena C; Bartoli E
Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337
[No Abstract] [Full Text] [Related]
8. Losartan versus captopril in elderly patients with heart failure.
Jensen BV; Nielsen SL
Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335
[No Abstract] [Full Text] [Related]
9. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE).
Pitt B; Segal R; Martinez FA; Meurers G; Cowley AJ; Thomas I; Deedwania PC; Ney DE; Snavely DB; Chang PI
Lancet; 1997 Mar; 349(9054):747-52. PubMed ID: 9074572
[TBL] [Abstract][Full Text] [Related]
10. Involvement of angiotensin II type 1 receptor on pathological remodeling and dysfunction in obstructed bladder.
Aikawa K; Sakai T; Ishibashi K; Shiomi H; Sagawa K; Kumagai S; Kataoka M; Akaihata H; Yamaguchi O
Int J Urol; 2012 May; 19(5):457-64. PubMed ID: 22320898
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of angiotensin II, bradykinin, and prostaglandins to the renal effects of converting enzyme inhibition in rats after chronic myocardial infarction.
Deck CC; Gaballa MA; Raya TE
J Cardiovasc Pharmacol; 1996 Jul; 28(1):167-74. PubMed ID: 8797151
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model.
Comiter C; Phull HS
BJU Int; 2012 Jun; 109(12):1841-6. PubMed ID: 21939491
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats.
Capasso JM; Li P; Meggs LG; Herman MV; Anversa P
J Cardiovasc Pharmacol; 1994 Apr; 23(4):584-93. PubMed ID: 7516008
[TBL] [Abstract][Full Text] [Related]
14. Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.
Cao Z; Bonnet F; Davis B; Allen TJ; Cooper ME
Clin Sci (Lond); 2001 Jun; 100(6):591-9. PubMed ID: 11352773
[TBL] [Abstract][Full Text] [Related]
15. AT1-receptor antagonists for the treatment of chronic heart failure.
Baan J
Cardiovasc Res; 1999 Jan; 41(1):14-5. PubMed ID: 10325947
[No Abstract] [Full Text] [Related]
16. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
17. Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
Morrell NW
Chest; 1997 May; 111(5):1469-70. PubMed ID: 9149625
[No Abstract] [Full Text] [Related]
18. Angiotensin receptor antagonists.
Goldsmith DJ
Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
[No Abstract] [Full Text] [Related]
19. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
20. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
